If you answered YES you may be eligible to participate in the PROGRESS Trial.
This study will involve women who had a spontaneous pre-term birth at less than 37 weeks in the previous pregnancy and will assess whether vaginal progesterone given from 20 to 34 weeks, compared with a placebo, reduces the chance of a preterm birth and the associated breathing difficulties and problems for the baby. The results of this study will help provide reliable information about the effectiveness of progesterone to guide clinical care.
Are you interested in being involved? Would you like to know more about this study? You can email us at firstname.lastname@example.org with the subject line PROGRESS.
1. Ask your doctor or midwife for more details
2. Contact our investigator: Professor Marie-France Delisle, 604-875-3054 or email email@example.com
PROGESTERONE AFTER PREVIOUS PRETERM BIRTH FOR THE PREVENTION OF NEONATAL RESPIRATORY DISTRESS SYNDROME